Company News: Page (1) of 1 - 12/29/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs

  (December 29, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Presentors,Business Issues,Presentation,People,Events,USA,Brazil,Medicine,healthcare,Cancer,Surgery,Medication,Womens Health,Science,Lifestyle,Medical,Cancer,Other,Women,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved